Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet
The purpose of this study is to demonstrate that treatment with etelcalcetide (AMG 416) is
not inferior to treatment with cinacalcet for lowering serum parathyroid hormone (PTH)
levels by > 30% from baseline among patients with chronic kidney disease (CKD) and secondary
hyperparathyroidism (SHPT) who require management with hemodialysis.
A Single-dose Study in Paediatric Subjects Aged 2 to Less Than 18 Years With (sHPT) Receiving Haemodialysis
Not yet recruiting
This is a multicenter, open-label study to evaluate the safety and pharmacokinetics in
pediatric subjects with secondary hyperparathyroidism receiving a single dose of AMG 416 at
the end of hemodialysis.
Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian HD Subjects With SHPT
Not yet recruiting
To demonstrate that treatment with etelcalcetide (AMG 416) is not inferior to treatment with
cinacalcet for lowering serum intact parathyroid hormone (PTH) levels by > 30% from baseline
among subjects with chronic kidney disease (CKD) and secondary hyperparathyroidism (SHPT) who
require management with hemodialysis.
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.